Skip to main content

August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights

Quality Improvement Programs Enhance Diabetes Care, Especially When Baseline Measures Are Poor

TODAY Study: New Data, Implications for Young Patients with Diabetes

Achieving Normoglycemia, Even Once, Significantly Reduces Diabetes Risk in Patients with Prediabetes

Empagliflozin Safe and Effective with or without Metformin, Reduces Weight

Early Intensive Therapy in Type 2 Diabetes Preserves Beta-Cell Function

Lixisenatide Continues to Show Good Results in GetGoal Program Studies

New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine

The Ancient Anti-Inflammatory Drug Salsalate Lowers Blood Glucose Levels

Diabetes Drug Pipeline: Promising Agents in Late Stages of Development

Medical Spending for Diabetes, 1987-2008: Where Does the Money Go?

Page 3 of 4
Results 21 - 30 of 32